Repository logo
 
Publication

Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel

2024-01Journal article Open access
Simple item page
dc.contributor.authorFernandes, M. G. O.
dc.contributor.authorVilariça, A. S.
dc.contributor.authorFernandes, B.
dc.contributor.authorCamacho, C.
dc.contributor.authorSaraiva, C.
dc.contributor.authorEstevinho, F.
dc.contributor.authorBastos, H. Novais e
dc.contributor.authorLopes, J. M.
dc.contributor.authorFidalgo, P.
dc.contributor.authorGarrido, P.
dc.contributor.authorAlves, S.
dc.contributor.authorSilva, S.
dc.contributor.authorSequeira, T.
dc.contributor.authorBarata, F.
dc.date.accessioned2024-12-11T10:22:12Z
dc.date.available2024-12-11T10:22:12Z
dc.date.issued2024-01
dc.description.abstractThe management of NSCLC remains challenging, and the integration of data from predictive biomarkers in routine clinical practice can contribute to an optimal, individualized patient approach, particularly given the rapid emergence of effective targeted therapies. When considering molecular biomarker testing, the choice of the biomarker panel, target population, testing approach, and turnaround time are key issues that, when properly addressed, can improve the survival outcomes of NSCLC patients.eng
dc.description.sponsorshipBoehringer Ingelheim Portuga by Prime Focus
dc.identifier.doi10.1016/j.pulmoe.2022.11.009
dc.identifier.issn2531-0437
dc.identifier.urihttp://hdl.handle.net/10400.1/26447
dc.language.isoeng
dc.peerreviewedyes
dc.publisherInforma UK Limited
dc.relation.hasversionhttps://www.sciencedirect.com/science/article/pii/S2531043723000028?via%3Dihub
dc.relation.ispartofPulmonology
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectOf American Pathologists
dc.subjectTesting Guideline
dc.subjectAcquire resistance
dc.subjectClinical Oncology
dc.subjectEGFR mutation
dc.subjectAssociation
dc.subjectCollege
dc.subjectSelection
dc.subjectNSCLC
dc.subjectALK
dc.titleImproving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage7
oaire.citation.issue1
oaire.citation.startPage4
oaire.citation.titlePulmonology
oaire.citation.volume30
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel.pdf
Size:
281.56 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.46 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

ULS_10.1-MED-Artigos